XENPOZYME Trademark

Trademark Overview

On Thursday, March 7, 2019, a trademark application was filed for XENPOZYME with the United States Patent and Trademark Office. The USPTO has given the XENPOZYME trademark a serial number of 88330513. The federal status of this trademark filing is REGISTERED as of Tuesday, January 17, 2023. This trademark is owned by Genzyme Corporation. The XENPOZYME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
xenpozyme

General Information

Serial Number88330513
Word MarkXENPOZYME
Filing DateThursday, March 7, 2019
Status700 - REGISTERED
Status DateTuesday, January 17, 2023
Registration Number6957890
Registration DateTuesday, January 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 26, 2019
Primary Code005
First Use Anywhere DateFriday, September 16, 2022
First Use In Commerce DateFriday, September 16, 2022

Trademark Owner History

Party NameGenzyme Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameGenzyme Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameGenzyme Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 17, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 13, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 28, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, September 23, 2022USE AMENDMENT FILED
Friday, September 23, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, April 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 8, 2022SOU EXTENSION 5 GRANTED
Monday, April 4, 2022SOU EXTENSION 5 FILED
Friday, April 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 4, 2022TEAS EXTENSION RECEIVED
Friday, October 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021SOU EXTENSION 4 GRANTED
Wednesday, October 13, 2021SOU EXTENSION 4 FILED
Wednesday, October 13, 2021TEAS EXTENSION RECEIVED
Wednesday, May 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 10, 2021SOU EXTENSION 3 GRANTED
Monday, May 10, 2021SOU EXTENSION 3 FILED
Monday, May 10, 2021TEAS EXTENSION RECEIVED
Wednesday, September 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2020SOU EXTENSION 2 GRANTED
Monday, September 21, 2020SOU EXTENSION 2 FILED
Monday, September 21, 2020TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 17, 2020SOU EXTENSION 1 GRANTED
Friday, April 17, 2020SOU EXTENSION 1 FILED
Friday, April 17, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2019ASSIGNED TO LIE
Saturday, August 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2019NON-FINAL ACTION WRITTEN
Sunday, March 31, 2019ASSIGNED TO EXAMINER
Tuesday, March 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 11, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

xenpozyme diseases preparations pharmaceutical treatment prevention namely infectious rare infections bacterial